MDedge, a scientific e-newsletter, on Friday reported that hydroxychloroquine (HCQ) is currently the first-line treatment and Tocilizumab the second-line medicine for other people hospitalized with polymerase chain reaction-confirmed COVID-19 infection in the Yale New Haven Health System, which operates hospitals throughout Connecticut.
No comments